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A 17-year-old female was admitted to our emergency 
room 30 min after suicidal ingestion of about 10 g Tramadol. 
The patient had several short-lived clonic seizures before 
admission. On arrival, she had an episode of tonic-clonic 
seizure, lasting for three minutes, which lead to 
cardiopulmonary arrest after administration of 10 mg 
diazepam intravenously. Endotracheal intubation and 
cardiopulmonary resuscitation were attempted. After 
30 min, normal sinus rhythm with a palpable pulse was 
noted, and the patient was put on mechanical ventilation 
and transferred to the intensive care unit (ICU). Her vital 
signs were stable with vasopressor medication support 
(norepinephrine infusion at 10 µg min-1). She had repeated 
short-lived tonic-clonic seizure-like movements, which 
responded well to midazolam. Her past medical and family 
history was negative for seizure, heart diseases, and 
hereditary disorders. Repeated neurological examination 
indicated that the patient had no motor response to pain and 
had fixed dilated pupils without corneal and vestibulo-
ocular reflexes. About 48 h after admission to the ICU, she 
experienced asystole, which did not respond to resuscitation. 
Tramadol HCl is a synthetic opioid drug that blocks 
reuptake of monoamine and inhibits NMDA glutamatergic 
activity, while it has low affinity for mu-opioid receptors 
(1). It has a low potential for abuse and is usually prescribed 
for control of moderate to severe pain (2). Tramadol is 
mainly metabolised by the hepatic cytochrome P450 2D6 
(CYP2D6), and its active metabolites are responsible for 
complications, meaning that in a CYP2D6 rapid metaboliser 
patient excessive side effects may develop within a short 
time following its overdose (2, 3).
It has been reported that the LD50 value for Tramadol 
is about 300-350 mg kg-1 body weight in animal models 
(4). However, reviewing the literature, we found that it is 
generally considered to be non–life threatening in humans, 
hence, co-ingestion of Tramadol and other agents such as 
analgesics, muscle relaxants, and CNS depressants is 
occasionally reported from toxicological samples of 
postmortem human specimens (2, 5). In fact, there are only 
a few case reports of human fatality due to Tramadol 
overdose alone (2). It has been suggested that CYP2D6 
ultra-rapid metaboliser patients may develop fatal 
complications (5). As its overstated toxic manifestations 
and accordingly its fatality are prospected during the first 
hours, which is related to its metabolism (5), this time is 
crucial in patient's care. Moreover, in the emergency 
situation, we have no idea about the activity of the 
cytochrome P450 2D6 in patients with Tramadol overdose, 
which can be induced by other drugs. Therefore, as 
cardiopulmonary arrest can be a fatal complication (5), we 
strongly suggest that all patients with exaggerated signs or 
symptoms of toxicity who consumed more than 150 mg kg-1 
(the half dose of LD50 values in animal models) of Tramadol 
(4), should be intubated prophylactically and sedated with 
benzodiazepines, at least for the first nine hours, the reported 
half-life of Tramadol in human overdose (3). However, 
properly designed studies need to be conducted on this topic 
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